An untargeted lipidomic analysis reveals depletion of several phospholipid classes in patients with familial hypercholesterolemia on treatment with Evolocumab®. (August 2022) - Calcaterra, I.; Di Minno, A.; Anesi, A.; Cavalca, V.; Tripaldella, M.; Tremoli, E.; Iannuzzo Di Taranto, G.; Fortunato, G.; Di Minno, M.N.D.